Efficacy and safety of Gelsectan for diarrhoea‐predominant irritable bowel syndrome: A randomised, crossover clinical trial

201953 citationsJournal Articlebronze Open Access

Authors

XG + PPT + XOS effectively controlled diarrhoea and alleviated clinical symptoms in patients with IBS-D, and was well tolerated.

Published in: United European Gastroenterology Journal

Volume 7, Issue 8, pp. 1093-1101

Field-Weighted Citation Impact: 4.59